ROBERT OLIVER

BIRMINGHAM, AL NPI 1891880928

General Payments — all program years on this page

$5,556.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,233.19 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Long term medical supply or device loan $1,427.852
Travel and Lodging $1,155.003
Food and Beverage $650.3413

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $35.942
2019 $110.356
2020 $128.904
2021 $1,376.5222
2022 $397.7213
2023 $273.454
2024 $3,233.1918

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1128565477 Musculoskeletal Transplant Foundation Inc. $768.40 04/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1128565919 Musculoskeletal Transplant Foundation Inc. $127.50 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128570911 Musculoskeletal Transplant Foundation Inc. $261.10 01/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1128570970 Musculoskeletal Transplant Foundation Inc. $125.50 05/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139155054 MOTIVA USA, LLC $24.27 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140129206 Integra LifeSciences Corporation $155.68 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140129210 Integra LifeSciences Corporation $141.57 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140129214 Integra LifeSciences Corporation $776.25 08/09/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1140129218 Integra LifeSciences Corporation $651.60 09/09/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1151257615 Pacira Pharmaceuticals Incorporated $24.63 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151257617 Pacira Pharmaceuticals Incorporated $26.16 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270501 TELA Bio, Inc. $20.21 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270503 TELA Bio, Inc. $21.11 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270505 TELA Bio, Inc. $19.21 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270507 TELA Bio, Inc. $22.26 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270509 TELA Bio, Inc. $17.89 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270511 TELA Bio, Inc. $26.85 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154270513 TELA Bio, Inc. $23.00 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.